Introduction
============

Atrial fibrillation (AF) is the most common tachyarrhythmia ([@b1-etm-06-02-0489]). The incidence of AF is 3--5% in individuals aged \>65 years and 9% in individuals aged \>80 years ([@b2-etm-06-02-0489]). The incidence of cerebral apoplexy and heart failure is increased in patients with AF since the heart atrium loses mechanical function with slow blood flow ([@b3-etm-06-02-0489],[@b4-etm-06-02-0489]). AF is the strongest independent risk factor for cerebral apoplexy and heart failure; 15% of cerebral apoplexy and 30% of heart failure cases are associated with AF and the mortality rate of patients with AF is three times the mortality rate of patients with sinus rhythm ([@b5-etm-06-02-0489]). Compared with other types of AF, chronic persistent AF is more complex and is difficult to treat. According to the AF treatment guidelines produced by the American College of Cardiology, American Heart Association and European Society of Cardiology (ACC/AHA/ESC) in 2006, chronic AF is defined as AF that persistently exists following drug therapy or electroversion ([@b6-etm-06-02-0489]).

A great deal of attention has been paid to radiofrequency catheter ablation for the treatment of chronic AF. The relapse rate of radiofrequency catheter ablation is 20--60% in the treatment of chronic AF ([@b7-etm-06-02-0489]--[@b9-etm-06-02-0489]). At present, there is no standard radiofrequency catheter ablation method for the treatment of chronic AF. The main methods of radiofrequency catheter ablation for treating chronic AF include pulmonary vein isolation (PVI), pulmonary vein antrum isolation (PVAI), circumferential pulmonary vein isolation (CPVI), complex fractionated atrial electrogram (CFAE) and PVI plus left atrial ablation (LAA). There has been considerable debate about the treatment of chronic AF with drugs or radiofrequency catheter ablation.

In order to compare the therapeutic effects of drug therapy and radiofrequency catheter ablation, as well as compare different procedures of radiofrequency catheter ablation, papers published in China and elsewhere between January 1, 2002 and May 1, 2012 concerning the treatment of chronic AF with drug or radiofrequency catheter ablation were retrieved and then analyzed with the RevMan 5.1 software package. This study discusses different strategies for the treatment of chronic AF.

Materials and methods
=====================

Paper retrieval
---------------

Papers published in China and other countries between January 1, 2002 and May 1, 2012, which reported the success rates and relapse rates of drug therapy and catheter ablation for the treatment of chronic AF were retrieved. Databases used were Chinese HowNet, VIP, Wanfang, Medline, Wiley, SpringerLink, Google Scholar and Science Direct.

The search items included the title, keyword and abstract. The following English search terms and the corresponding Chinese terms were used: atrial fibrillation, ablation/catheter ablation, drugs/anti-arrhythmia and chronic atrial fibrillation/permanent atrial fibrillation.

Inclusion and exclusion criteria
--------------------------------

Inclusion criteria were as follows: i) papers published in China and other countries between January 1, 2002 and May 1, 2012; ii) randomized controlled trials (RCTs); iii) patients with chronic AF; iv) clear diagnostic criteria: drugs did not effectively maintain sinus rhythm or persistent AF for \>7 days repeated within 6 months; v) data collection with a scientific method; vi) data analysis with a correct and scientific method; vii) interventions including radiofrequency catheter ablation and drug therapy; and viii) only one paper selected from several papers about the same population. Exclusion criteria were as follows: i) non-RCT; ii) data collection with a non-scientific method; iii) data analysis with non-scientific method; iv) literature reviews and v) repeated papers.

Quality evaluation
------------------

The quality of papers was evaluated according to the quality evaluation criteria described in v.4.2.2 of the Cochrane System Assessment handbook. The quality of papers was divided into grades A, B and C based on the randomized method, hidden method, double-blind method, loss of follow-up and exodus of patients from the study. Grade A had low bias and the lowest possibility of bias, and completely conformed to the four quality standards. The four quality standards include randomized method, hidden method, double-blind method, and loss of follow-up and exodus of patients. Grade B had moderate bias and a moderate possibility of bias, and partially conformed to ≥1 quality standards. Grade C had high bias and a high possibility of bias, and did not conform to ≥1 quality standards completely.

Statistical analysis
--------------------

According to the requirements of the meta-analysis, data processing was performed and a database was established. Data analysis was performed with the RevMan 5.1 software package. The therapeutic effects of catheter ablation and drug therapy for chronic AF were analyzed, with the odds ratio (OR) as an effective index, and the OR and 95% confidence interval (CI) were calculated. Specific steps were as follows: i) OR served as the summary statistic; ii) an homogeneity test was performed using the χ^2^ test. If P\>0.1, multiple independent studies had homogeneity and OR was calculated with the fixed effect model. If P≤0.1, multiple independent studies had heterogeneity and after sensitivity or stratified analyses, the data had homogeneity; then OR was calculated with the fixed effect model. Otherwise OR was calculated with the random effect model; iii) the probability value of the summary statistic was first obtained with the U test. If P≤0.05 was considered to indicate a statistically significant difference; iv) the publication bias was identified with funnel plots. The funnel plots were generated by the RevMan 5.1 software package, with OR values as the x-axis and with SE (log OR) as the y-axis. The publication bias was evaluated by observing whether the funnel plot was symmetrical.

Results
=======

Paper retrieval
---------------

A total of 20 papers ([@b10-etm-06-02-0489]--[@b29-etm-06-02-0489]) were used in this study. Of the 20 papers, eight compared drug therapy with radiofrequency catheter ablation; five compared PVAI and PVAI + CFAE, of which two papers also compared PVAI alone and CFAE alone; four compared PVI + LAA and PVI; and three compared PVI and CPVI ([Table I](#t1-etm-06-02-0489){ref-type="table"}).

Comparison of success rates between catheter ablation and drug therapy
----------------------------------------------------------------------

There were eight papers ([@b10-etm-06-02-0489]--[@b17-etm-06-02-0489]) that compared the success rates of catheter ablation and drug therapy. These papers included a total of 951 patients, with catheter ablation as the test group and drug therapy as the control group ([Table II](#t2-etm-06-02-0489){ref-type="table"}).

In the eight papers, there were 476 patients in the test group and 475 patients in the control group. The homogeneity test (χ^2^=30.58, v=7, P\<0.0001) demonstrated that the eight papers had heterogeneity; therefore, the random effect model was adopted. The OR value was 8.94 (95% CI, 4.70--17.02; z=6.68; P\<0.0001), suggesting that the success rate was significantly higher for catheter ablation compared with that for drug therapy ([Fig. 1](#f1-etm-06-02-0489){ref-type="fig"}).

Comparison of relapse rates between catheter ablation and drug therapy for treatment of chronic AF
--------------------------------------------------------------------------------------------------

There were seven papers ([@b10-etm-06-02-0489],[@b11-etm-06-02-0489],[@b13-etm-06-02-0489]--[@b17-etm-06-02-0489]) that compared the relapse rates of catheter ablation and drug therapy for treatment of chronic AF. The seven papers included a total of 753 patients, with catheter ablation as the test group and drug therapy as the control group ([Table III](#t3-etm-06-02-0489){ref-type="table"}).

In the seven papers, there were 377 patients in the test group and 376 patients in the control group. The homogeneity test (χ^2^=5.87, v=6, P=0.44, P\>0.10) demonstrated that the seven papers had homogeneity; therefore, the fixed effect model was adopted. The OR value was 0.07 (95% CI, 0.05--0.10; z=14.06; P\<0.0001), suggesting that the relapse rate was significantly lower for catheter ablation compared with that for drug therapy ([Fig. 2](#f2-etm-06-02-0489){ref-type="fig"}).

Comparison of success rates between PVAI and CFAE
-------------------------------------------------

There were two papers ([@b18-etm-06-02-0489],[@b19-etm-06-02-0489]) comparing the success rates of PVAI and CFAE for treatment of chronic AF. The two papers included a total of 128 patients, with PVAI as the test group and CFAE as the control group ([Table IV](#t4-etm-06-02-0489){ref-type="table"}).

In the two papers, there were 70 patients in the test group and 58 patients in the control group. The homogeneity test (χ^2^=28.47, v=1, P=0.0000, P\<0.10) demonstrated that the two papers did not have homogeneity; therefore, the random effect model was adopted. The OR value was 2.05 (95% CI, 0.06--205.74; z=0.30; P=0.76), suggesting that there was no significant difference in success rates between PVAI and CFAE for treatment of chronic AF ([Fig. 3](#f3-etm-06-02-0489){ref-type="fig"}).

Comparison of success rates between PVA I and PVAI + CFAE
---------------------------------------------------------

There were five papers ([@b18-etm-06-02-0489]--[@b22-etm-06-02-0489]) comparing the success rates of PVAI and PVAI + CFAE for treatment of chronic AF. The five papers included a total of 559 patients, with PVAI as the test group and PVAI + CFAE as the control group ([Table V](#t5-etm-06-02-0489){ref-type="table"}).

In the five papers, there were 268 patients in the test group and 291 patients in the control group. The homogeneity test (χ^2^=5.98, v=4, P=0.20, P\>0.10) demonstrated that the papers had homogeneity; therefore, the fixed effect model was adopted. The OR value was 0.53 (95% CI, 0.37--0.78; z=3.23; P=0.001), suggesting that the success rate for treatment of chronic AF was significantly higher for PVAI + CFAE than for PVAI ([Fig. 4](#f4-etm-06-02-0489){ref-type="fig"}).

Comparison of success rates between PVI and PVI + LAA
-----------------------------------------------------

There were four papers ([@b23-etm-06-02-0489]--[@b26-etm-06-02-0489]) in which the success rates of PVI and PVI + LAA in the treatment of chronic AF were compared. These papers included a total of 322 patients, with PVI + LAA as the test group and PVI as the control group ([Table VI](#t6-etm-06-02-0489){ref-type="table"}).

In the four papers, there were 162 patients in the test group and 160 patients in the control group. The homogeneity test (χ^2^=2.71, v=3, P=0.44, P\>0.10) demonstrated that the papers had homogeneity; therefore, the fixed effect model was adopted. The OR value was 2.79 (95% CI, 1.59--4.88; z=3.59; P=0.0003), suggesting that the success rate was significantly higher for PVI + LAA compared with that for PVI ([Fig. 5](#f5-etm-06-02-0489){ref-type="fig"}).

Comparison of success rates between PVI and CPVI
------------------------------------------------

There were three papers ([@b27-etm-06-02-0489]--[@b29-etm-06-02-0489]) in which the success rates of PVI and CPVI were compared. The three papers included a total of 310 patients, with PVI as the test group and CPVI as the control group ([Table VII](#t7-etm-06-02-0489){ref-type="table"}).

In the three papers, there were 150 patients in the test group and 160 patients in the control group. The homogeneity test (χ^2^=12.82, v=2, P=0.002, P\<0.10) demonstrated that the papers did not have homogeneity; therefore, the random effect model was adopted. The OR value was 0.94 (95% CI, 0.29--3.00; z=0.11; P=0.91), suggesting that there were no significant differences in the success rates between PVI and CPVI for treatment of chronic AF ([Fig. 6](#f6-etm-06-02-0489){ref-type="fig"}).

Publication bias
----------------

All funnel plots comparing the success rates of catheter ablation and drug therapy, PVAI and CFAE, PVAI and PVAI + CFAE, PVI + LAA and PVI, and PVI and CPVI were essentially symmetrical, and the majority of the points were located within the 95% CI. The funnel plot comparing the relapse rates of catheter ablation and drug therapy was essentially symmetrical and the majority of the points were located within the 95% CI.

Discussion
==========

In this study, a meta-analysis of catheter ablation and drug therapy for the treatment of chronic AF was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The results indicated that for the treatment of chronic AF, the success rate is higher and the relapse rate is lower for catheter ablation compared with that for drug therapy. There were no significant differences between the success rates of PVAI and CFAE, and PVI and CPVI; however, the success rates were higher for PVAI + CFAE compared with that for PVAI, and for PVI + LAA compared with that for PVI. The results of publication bias indicated that the results of the meta-analysis were stable and reliable, truly reflecting the status of catheter ablation and drug treatment of chronic AF.

AF treatment includes rate control and rhythm control. Although it has been reported that rate control is a reasonable choice for the treatment of AF ([@b30-etm-06-02-0489]), rate control alone does not reduce the risk of cerebral apoplexy and improve atrioventricular synchrony. Antithrombotic therapy with warfarin decreases the incidence of cerebral apoplexy and reduces the mortality rate; however, there is the risk of bleeding, which requires long-term monitoring of international normalized ratio (INR) of prothrombin time with low patient compliance. Compared with rate control, rhythm control decreases the mortality rate and the incidence of transient ischemic attack (TIA), cerebral infarction ([@b31-etm-06-02-0489]), systemic embolism, hemorrhea and heart failure ([@b32-etm-06-02-0489]). Therefore, rhythm control is likely to be more effective than rate control. The conventional methods of rhythm control include anti-arrhythmic drugs, direct current countershock and the surgical maze procedure. However, these methods are limited in clinical practice due to their therapeutic effects and safety. In the past 20 years, a great deal of attention has been paid to catheter ablation for the treatment of AF. In the AF treatment guidelines established by ACC/AHA/ESC in 2008, catheter ablation is suitable for patients who exhibit no therapeutic effects following treatment with class I or III anti-arrhythmic drugs, are unable to tolerate the side-effects of drugs or have symptomatic heart failure or low cardiac output prior to the use of anti-arrhythmic drugs.

The pathogenesis of AF is not completely clear. At present, its mechanism mainly includes triggering factors and an electrical substrate (or atrial substrate). The majority of the triggering factors are located in the pulmonary veins and superior vena cava; however, a few triggering factors are located in the crista terminalis, coronary sinus, Marshall ligaments and atrial posterior wall. Triggering factors are also called triggering foci. Electrical substrate refers to the changes in electrophysiological characteristics to maintain AF and mainly includes electrical reconstitution, anatomical reconstitution, reconstitution of autonomic nerves and reconstitution of the renin-angiotensin system. Atrial dilatation, myocarditis, myocardial fibrosis and increased autonomic nervous tension all serve as triggering factors and/or an electrical substrate to lead to AF. Triggering factors and the electrical substrate may be located in the same place or at different locations. Radiofrequency ablation is used to treat AF through the isolation of triggering factors and interference with the electrical substrate ([@b33-etm-06-02-0489],[@b34-etm-06-02-0489]).

The limitations of the current study are that only a small number of papers were included in the study, unpublished papers from conferences were not included and the quality control standards were not completely uniform. Future meta-analyses should include a greater number of RCTs.

Our results suggest that catheter ablation is more effective than drug therapy in the treatment of AF. There are no significant differences in success rates between two single procedures for catheter ablation; however, the success rate is higher in PVAI + CFAE compared with that in PVAI, and in PVI + LAA compared with that in PVI.
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![Comparison of success rates between PVAI and CFAE. PVAI, pulmonary vein antrum isolation; CFAE, complex fractional atrial electrogram.](ETM-06-02-0489-g02){#f3-etm-06-02-0489}

![Comparison of success rates between PVAI and PVAI + CFAE for the treatment of chronic AF. PVAI, pulmonary vein antrum isolation; CFAE, complex fractionated atrial electrogram; AF, atrial fibrillation.](ETM-06-02-0489-g03){#f4-etm-06-02-0489}

![Comparison of success rates between PVI + LAA and PVI. PVI, pulmonary vein isolation; LAA, left atrial ablation.](ETM-06-02-0489-g04){#f5-etm-06-02-0489}

![Comparison of success rates between PVI and CPVI. PVI, pulmonary vein isolation; CPVI, circumferential pulmonary vein isolation.](ETM-06-02-0489-g05){#f6-etm-06-02-0489}

###### 

Original papers included in this meta-analysis.

  No. (ref.)                   Publication date (year)   First author          Title of paper
  ---------------------------- ------------------------- --------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1 ([@b10-etm-06-02-0489])    2010                      David J. Wilber       Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial
  2 ([@b11-etm-06-02-0489])    2006                      Carlo Pappone         A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study
  3 ([@b12-etm-06-02-0489])    2011                      Carlo Pappone         Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study
  4 ([@b13-etm-06-02-0489])    2003                      R. Krittayaphong      A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation
  5 ([@b14-etm-06-02-0489])    2009                      Giovanni B. Forleo    Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy
  6 ([@b15-etm-06-02-0489])    2008                      Pierre Jaïs           Catheter ablation versus anti-arrhythmic drugs for atrial fibrillation: the A4 study
  7 ([@b16-etm-06-02-0489])    2006                      Hakan Oral            Circumferential pulmonary-vein ablation for chronic atrial fibrillation
  8 ([@b17-etm-06-02-0489])    2006                      Giuseppe Stabile      Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)
  9 ([@b18-etm-06-02-0489])    2009                      Luigi Di Biase        Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques
  10 ([@b19-etm-06-02-0489])   2011                      Minglong Chen         Randomized comparison between pulmonary vein antral isolation versus complex fractionated electrogram ablation for paroxysmal atrial fibrillation
  11 ([@b20-etm-06-02-0489])   2008                      Claude S. Elayi       Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies
  12 ([@b21-etm-06-02-0489])   2009                      Hakan Oral            A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation
  13 ([@b22-etm-06-02-0489])   2007                      Atul Verma            Efficacy of adjuvant anterior left atrial ablation during intracardiac echocardiography-guided pulmonary vein antrum isolation for atrial fibrillation
  14 ([@b23-etm-06-02-0489])   2006                      Stephan Willems       Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison
  15 ([@b24-etm-06-02-0489])   2005                      Mélèze Hocini         Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study
  16 ([@b25-etm-06-02-0489])   2004                      Michel Haïssaguerre   Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome
  17 ([@b26-etm-06-02-0489])   2006                      Imran Sheikh          Pulmonary vein isolation and linear lesions in atrial fibrillation ablation
  18 ([@b27-etm-06-02-0489])   2008                      Martin Fiala          Pulmonary vein isolation using segmental versus electro-anatomical circumferential ablation for paroxysmal atrial fibrillation: over 3-year results of a prospective randomized study
  19 ([@b28-etm-06-02-0489])   2005                      Martin R. Karch       Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies
  20 ([@b29-etm-06-02-0489])   2006                      Brian Nilsson         Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: a randomized trial of the ostial versus the extraostial ablation strategy

###### 

Papers comparing the success rates of catheter ablation and drug therapy for treatment of chronic atrial fibrillation.

  Number   Reference               Publication date (year)   First author         Test group (n)   Control group (n)        
  -------- ----------------------- ------------------------- -------------------- ---------------- ------------------- ---- ----
  1        [@b10-etm-06-02-0489]   2010                      David J. Wilber      23               30                  12   30
  2        [@b11-etm-06-02-0489]   2006                      Carlo Pappone        72               99                  12   99
  3        [@b12-etm-06-02-0489]   2011                      Carlo Pappone        85               99                  24   99
  4        [@b13-etm-06-02-0489]   2003                      R. Krittayaphong     11               15                  6    15
  5        [@b14-etm-06-02-0489]   2009                      Giovanni B. Forleo   28               35                  15   35
  6        [@b15-etm-06-02-0489]   2008                      Pierre Jaïs          46               53                  23   59
  7        [@b16-etm-06-02-0489]   2006                      Hakan Oral           57               77                  40   69
  8        [@b17-etm-06-02-0489]   2006                      Giuseppe Stabile     46               68                  14   69

###### 

Papers comparing the relapse rates of catheter therapy and drug therapy.

  Number   Reference               Publication date (year)   First author         Test group (n)   Control group (n)        
  -------- ----------------------- ------------------------- -------------------- ---------------- ------------------- ---- ----
  1        [@b10-etm-06-02-0489]   2010                      David J. Wilber      8                30                  25   30
  2        [@b11-etm-06-02-0489]   2006                      Carlo Pappone        14               99                  75   99
  3        [@b13-etm-06-02-0489]   2003                      R. Krittayaphong     3                15                  9    15
  4        [@b14-etm-06-02-0489]   2009                      Giovanni B. Forleo   7                35                  20   35
  5        [@b15-etm-06-02-0489]   2008                      Pierre Jaïs          7                53                  46   59
  6        [@b16-etm-06-02-0489]   2006                      Hakan Oral           14               77                  53   69
  7        [@b17-etm-06-02-0489]   2006                      Giuseppe Stabile     30               68                  63   69

###### 

Papers comparing the success rates of PVAI and CFAE.

  Number   Reference               Publication date (year)   First author     Test group (n)   Control group (n)        
  -------- ----------------------- ------------------------- ---------------- ---------------- ------------------- ---- ----
  1        [@b18-etm-06-02-0489]   2009                      Luigi Di Biase   26               35                  4    34
  2        [@b19-etm-06-02-0489]   2011                      Minglong Chen    13               35                  18   24

PVAI, pulmonary vein antrum isolation; CFAE, complex fractionated atrial electrogram.

###### 

Papers comparing the success rates of PVAI and PVAI + CFAE.

  Number   Reference               Publication date (year)   First author      Test group (n)   Control group (n)        
  -------- ----------------------- ------------------------- ----------------- ---------------- ------------------- ---- -----
  1        [@b18-etm-06-02-0489]   2009                      Luigi Di Biase    26               35                  25   34
  2        [@b19-etm-06-02-0489]   2011                      Minglong Chen     13               35                  40   58
  3        [@b20-etm-06-02-0489]   2008                      Claude S. Elayi   27               48                  39   49
  4        [@b21-etm-06-02-0489]   2009                      Hakan Oral        30               50                  34   50
  5        [@b22-etm-06-02-0489]   2007                      Atul Verma        80               100                 85   100

PVAI, pulmonary vein antrum isolation; CFAE, complex fractionated atrial electrogram.

###### 

Papers comparing the success rates of PVI + LAA and PVI.

  Number   Reference               Publication date (year)   First author          Test group (n)   Control group (n)        
  -------- ----------------------- ------------------------- --------------------- ---------------- ------------------- ---- ----
  1        [@b14-etm-06-02-0489]   2006                      Stephan Willems       19               32                  6    30
  2        [@b15-etm-06-02-0489]   2005                      Mélèze Hocini         39               45                  31   45
  3        [@b16-etm-06-02-0489]   2004                      Michel Haïssaguerre   29               35                  26   35
  4        [@b17-etm-06-02-0489]   2006                      Imran Sheikh          45               50                  41   50

PVI, pulmonary vein isolation; LAA, left atrial ablation.

###### 

Papers comparing the success rates of PVI and CPVI.

  Number   Reference               Publication date (year)   First author      Test group (n)   Control group (n)        
  -------- ----------------------- ------------------------- ----------------- ---------------- ------------------- ---- ----
  1        [@b27-etm-06-02-0489]   2008                      Martin Fiala      30               54                  32   56
  2        [@b28-etm-06-02-0489]   2005                      Martin R. Karch   33               50                  21   50
  3        [@b29-etm-06-02-0489]   2006                      Brian Nilsson     26               46                  16   54

PVI, pulmonary vein isolation; CPVI, circumferential pulmonary vein isolation.

[^1]: Contributed equally
